Literature DB >> 15383655

Role of oxidative modifications in atherosclerosis.

Roland Stocker1, John F Keaney.   

Abstract

This review focuses on the role of oxidative processes in atherosclerosis and its resultant cardiovascular events. There is now a consensus that atherosclerosis represents a state of heightened oxidative stress characterized by lipid and protein oxidation in the vascular wall. The oxidative modification hypothesis of atherosclerosis predicts that low-density lipoprotein (LDL) oxidation is an early event in atherosclerosis and that oxidized LDL contributes to atherogenesis. In support of this hypothesis, oxidized LDL can support foam cell formation in vitro, the lipid in human lesions is substantially oxidized, there is evidence for the presence of oxidized LDL in vivo, oxidized LDL has a number of potentially proatherogenic activities, and several structurally unrelated antioxidants inhibit atherosclerosis in animals. An emerging consensus also underscores the importance in vascular disease of oxidative events in addition to LDL oxidation. These include the production of reactive oxygen and nitrogen species by vascular cells, as well as oxidative modifications contributing to important clinical manifestations of coronary artery disease such as endothelial dysfunction and plaque disruption. Despite these abundant data however, fundamental problems remain with implicating oxidative modification as a (requisite) pathophysiologically important cause for atherosclerosis. These include the poor performance of antioxidant strategies in limiting either atherosclerosis or cardiovascular events from atherosclerosis, and observations in animals that suggest dissociation between atherosclerosis and lipoprotein oxidation. Indeed, it remains to be established that oxidative events are a cause rather than an injurious response to atherogenesis. In this context, inflammation needs to be considered as a primary process of atherosclerosis, and oxidative stress as a secondary event. To address this issue, we have proposed an "oxidative response to inflammation" model as a means of reconciling the response-to-injury and oxidative modification hypotheses of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383655     DOI: 10.1152/physrev.00047.2003

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  604 in total

1.  Metalloproteinase processing of HBEGF is a proximal event in the response of human aortic endothelial cells to oxidized phospholipids.

Authors:  Sangderk Lee; James R Springstead; Brian W Parks; Casey E Romanoski; Roland Palvolgyi; Tiffany Ho; Phuc Nguyen; Aldons J Lusis; Judith A Berliner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-08       Impact factor: 8.311

2.  Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.

Authors:  Xiaoli Wei; Man Ying; Diana Dehaini; Yuanyuan Su; Ashley V Kroll; Jiarong Zhou; Weiwei Gao; Ronnie H Fang; Shu Chien; Liangfang Zhang
Journal:  ACS Nano       Date:  2017-12-12       Impact factor: 15.881

3.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

4.  Malondialdehyde-derived epitopes in human skin result from acute exposure to solar UV and occur in nonmelanoma skin cancer tissue.

Authors:  Joshua D Williams; Yira Bermudez; Sophia L Park; Steven P Stratton; Koji Uchida; Craig A Hurst; Georg T Wondrak
Journal:  J Photochem Photobiol B       Date:  2014-02-12       Impact factor: 6.252

5.  Automated detection of superficial macrophages in atherosclerotic plaques using autofluorescence lifetime imaging.

Authors:  Jose J Rico-Jimenez; Michael J Serafino; Sebina Shrestha; Xi Chen; Wihan Kim; Jessie Adame; L Maximillan Buja; Deborah Vela; Brian E Applegate; Javier A Jo
Journal:  Atherosclerosis       Date:  2019-04-19       Impact factor: 5.162

6.  Low-level laser therapy (904nm) can increase collagen and reduce oxidative and nitrosative stress in diabetic wounded mouse skin.

Authors:  José Carlos Tatmatsu-Rocha; Cleber Ferraresi; Michael R Hamblin; Flávio Damasceno Maia; Nilberto Robson Falcão do Nascimento; Patricia Driusso; Nivaldo Antonio Parizotto
Journal:  J Photochem Photobiol B       Date:  2016-09-12       Impact factor: 6.252

7.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

Review 8.  Advances in the Pathogenesis of Adhesion Development: The Role of Oxidative Stress.

Authors:  Awoniyi O Awonuga; Jimmy Belotte; Suleiman Abuanzeh; Nicole M Fletcher; Michael P Diamond; Ghassan M Saed
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

9.  Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase.

Authors:  Muhammad Aslam; Klaus-Dieter Schluter; Susanne Rohrbach; Amir Rafiq; Sabiha Nazli; Hans Michael Piper; Thomas Noll; Rainer Schulz; Dursun Gündüz
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

10.  Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium.

Authors:  Ghassan J Maghzal; Katie M Cergol; Sudhir R Shengule; Cacang Suarna; Darren Newington; Anthony J Kettle; Richard J Payne; Roland Stocker
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.